Midlevel Versus Physician-provided Medical Abortion in the Second Trimester
Can Midlevel Providers Manage Medical Abortion in the Second Trimester as Safely and Effectively as Physicians? A Randomized Controlled Trial in Ethiopia
1 other identifier
interventional
245
1 country
1
Brief Summary
The purpose of the study is to determine the safety and effectiveness of second trimester medical abortion when provided by nurse midwives compared with physicians. The study sample will be obtained from Michu Clinic, affiliated with St Paul's hospital, in Addis Ababa.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2019
CompletedFirst Posted
Study publicly available on registry
November 29, 2019
CompletedStudy Start
First participant enrolled
February 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 24, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 3, 2021
CompletedSeptember 20, 2021
September 1, 2021
1 year
November 22, 2019
September 17, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to expulsion
Time to expulsion of fetus after medical abortion regimen initiated
Time (hours/minutes) from first dose of misoprostol until the fetus is expelled, up to 72 hours
Secondary Outcomes (5)
Total number of misoprostol doses
Time (hours/minutes) from first dose of misoprostol until the fetus and placenta are expelled, up to 72 hours
Need for ultrasound to confirm gestational age
At the time of eligibility for the abortion is assessed, need for confirmatory ultrasound recorded (up to 1 day)
Need for intervention by a physician
Assessed at the time of discharge and reflecting entire duration of hospitalization (up to 7 days)
Serious complications/ morbidity
Assessed at the time of discharge and reflecting entire duration of hospitalization (up to 7 days)
Adverse events
up to 7 days after discharge
Study Arms (2)
Women receiving abortion care by physicians
ACTIVE COMPARATORPatients who receive second trimester medical abortion care from a physician.
Women receiving abortion care from midlevel providers
EXPERIMENTALPatients who receive second trimester medical abortion care from a midlevel provider.
Interventions
In this cohort, women will receive second trimester medical abortion care from physicians
In this cohort, women will receive second trimester medical abortion care from midlevel providers.
Eligibility Criteria
You may qualify if:
- Willing and able to give consent for participation
- Intrauterine pregnancy with confirmed gestational age \>13 weeks and \<20 weeks
- Presenting for induced abortion at Michu Clinic
- Speaker of Amharic or Oromo
You may not qualify if:
- Women unable to give consent for participation
- Gestational age \<13 or \>20 weeks
- Adolescents aged less than 16 years
- Women with an allergy to or contraindications to mifepristone or misoprostol
- Women with a history of more than one previous hysterotomy
- Women seeking treatment for incomplete abortion, intrauterine fetal demise, or postabortion care
- Women with chronic hypertension or adrenal failure
- Women on chronic steroid treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Paul's Hospital Millennium Medical College
Addis Ababa, Ethiopia
Study Officials
- PRINCIPAL INVESTIGATOR
Nathalie Kapp, MD, MPH
Ipas
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2019
First Posted
November 29, 2019
Study Start
February 17, 2020
Primary Completion
February 24, 2021
Study Completion
March 3, 2021
Last Updated
September 20, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share